XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Organization , Description of Business and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Third-party Payers as a Percentage of Total
The Company’s total third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:
 
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Medicare33 %31 %33 %31 %
UnitedHealthcare14 %14 %13 %14 %
 47 %45 %46 %45 %

The Company's significant third-party payers in excess of 10% of total accounts receivable and their related accounts receivable balance as a percentage of total accounts receivable were as follows:
 
 June 30, 2025December 31, 2024
Medicare19 %16 %
UnitedHealthcare11 %12 %
Schedule of Revenue Revenue included in biopharmaceutical and other revenue for the three and six months ended June 30, 2025 and 2024 was as follows (in thousands of dollars):
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Biopharmaceutical revenue$2,630 $1,702 $4,927 $2,656 
Contract manufacturing and testing1,673 1,850 2,960 3,900 
Total$4,303 $3,552 $7,887 $6,556